Cancer as a Metabolic Disease
Seyfried argues that cancer is fundamentally a mitochondrial metabolic disease, challenging the prevailing genetic view held by mainstream oncology for the last century.
14The Diary Of A CEO
Professor Thomas Seyfried challenges mainstream oncology, arguing that cancer is primarily a mitochondrial metabolic disease rather than a genetic one, and outlines strategies to starve tumors.
Professor Thomas Seyfried posits that cancer is a mitochondrial metabolic disease, not a genetic one, and that mainstream oncology has misunderstood this for 100 years. He suggests that by targeting the metabolic fuels of cancer cells, such as glucose and glutamine, patients can better manage the disease.
14Listen to the source episode
Continue in GenPod
Key takeaways
Seyfried argues that cancer is fundamentally a mitochondrial metabolic disease, challenging the prevailing genetic view held by mainstream oncology for the last century.
14Cancer cells feed on specific fuels, primarily glucose and glutamine. Seyfried's team uses strategies to starve these tumors, potentially making chemotherapy and immunotherapy more effective.
56Seyfried co-developed the Glucose Ketone Index (GKI) as a metric to manage cancer. Lowering GKI through methods like a ketogenic diet can help starve cancer cells and enhance treatment efficacy.
26Environmental factors, including microplastics and 'forever chemicals,' are identified as quiet drivers that damage mitochondria, contributing to the metabolic origins of cancer.
711Seyfried's team reports keeping glioblastoma patients alive for years using these metabolic strategies, an option he claims is rarely communicated to patients despite its potential impact.
811Ask GenPod next
“How does the Glucose Ketone Index (GKI) differ from traditional cancer biomarkers?”
“What are the specific environmental drivers that damage mitochondria according to Seyfried?”
“How does the 'press-pulse' therapeutic strategy work in treating glioblastoma?”
Background reading
The Researcher
Thomas Seyfried, PhD, is a professor of biology at Boston College and a leading researcher on the metabolic origins of cancer. He is the author of 'Cancer as a Metabolic Disease' and co-developer of the Glucose Ketone Index (GKI) and the 'press-pulse' therapeutic strategy.
2Questions
Seyfried argues that mainstream oncology has misunderstood cancer for 100 years by focusing primarily on genetics, whereas he views it as a mitochondrial metabolic disease.
14Lowering the GKI, potentially through a ketogenic diet, can starve cancer cells by reducing their primary fuels, making chemotherapy and immunotherapy more effective.
6Environmental drivers such as microplastics and 'forever chemicals' are identified as factors that quietly damage mitochondria, contributing to cancer.
711His team uses metabolic strategies, including the 'press-pulse' therapeutic approach and managing the Glucose Ketone Index, to starve tumors and improve patient longevity.
8Seyfried claims that despite the potential benefits of metabolic therapies, almost no patient is ever told this option exists within mainstream oncology.
8Experts
Professor of Biology at Boston College
2Sources and disclosure
The views expressed are those of the guest, and this conversation is intended for general informational purposes only. This podcast and its associated materials should not be used as a substitute for professional medical advice, diagnosis, or treatment.
1,700 Americans will die from cancer today. 70 every single hour. Professor Thomas Seyfried says it doesn't have to be this way, and that mainstream oncology has misunderstood cancer for 100 years.
Thomas Seyfried, PhD, is a professor of biology at Boston College and one of the world's leading researchers on the metabolic origins of cancer. He is author of the book 'Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer' and co-developer of the Glucose Ketone Index (GKI) and the “press-pulse” therapeutic strategy.
He explains:
◼ Why he believes cancer is a mitochondrial metabolic disease, not a genetic one
◼ Why cancer cells feed on two fuels and the strategy his team uses to starve tumors
◼ How a ketogenic diet could lower your GKI and make chemo and immunotherapy work better
◼ The environmental drivers quietly damaging your mitochondria
◼ How his team is keeping glioblastoma patients alive for years, and why almost no patient is ever told this option exists
The views expressed are those of the guest, and this conversation is intended for general informational purposes only. This podcast and its associated materials should not be used as a substitute for professional medical advice, diagnosis, or treatment.
Chapters
• 00:00:00 Intro • 00:02:22 The New Discovery About Cancer • 00:03:23 What Role Do Mitochondria Play in Cancer? • 00:07:52 ATP & Fermentation: How Your Cells Make Energy • 00:14:40 The Oncogenic Paradox Finally Explained • 00:19:59 Ghost Mitochondria: Cancer Under the Microscope • 00:24:59 Glucose & Glutamine: The Fuels That Feed Cancer • 00:26:12 Why Do Children & Babies Get Cancer? • 00:29:05 Why Wealthy Countries Have More Cancer • 00:32:35 Is Cancer Genetic? • 00:37:38 The Prescription: The Glucose Ketone Index • 00:40:03 How Stress & Poor Sleep Fuel Cancer • 00:44:34 What's Inside the Confidential Envelope? • 00:45:38 The Patient Who Inspired the Discovery • 00:50:05 Measuring Your Glucose Ketone Index Live • 00:52:41 The 'Red Zone' Link To Cancer • 00:57:42 The Man Who Survived Glioblastoma for 10 Years • 00:58:35 Using the Keto Diet to Supercharge Chemo • 01:07:12 The Experiment That Could Prove Cancer Isn't Genetic • 01:08:10 1,700 Cancer Deaths a Day: Seyfried's Warning • 01:13:21 Seyfried's Plan to End the Cancer Epidemic • 01:16:05 What Foods You Should Actually Eat • 01:21:38 Fasting Protocols & Hitting 'The Wall' • 01:26:28 Hyperbaric Oxygen Therapy & Cancer • 01:28:10 Microplastics & 'Forever Chemicals' • 01:30:27 How Cancer Spreads: Metastasis Explained • 01:37:07 The #1 Actionable Takeaway • 01:39:25 Energy, Hope & Final Words
Follow Professor Thomas:
◼Instagram - https://link.thediaryofaceo.com/1MRuOwr
◼X - https://link.thediaryofaceo.com/DDF9xxr
◼Substack - https://link.thediaryofaceo.com/HKsGFcF
◼ Professor Seyfried's Biology Department - https://link.thediaryofaceo.com/HKwWhwD
◼ Foundation for Cancer Metabolic Therapies - https://link.thediaryofaceo.com/6Ehj3Hh
◼ Elizabeth Ann Weathers Breast Cancer Research Fund - https://link.thediaryofaceo.com/Bf10aHy
A message from Professor Seyfried: “If you would like to support research on the mitochondrial metabolic theory of cancer, please consider donating to our research. Please remember that no donation amount is too small or too large.”
The Diary Of A CEO:
◼ Join DOAC circle here - https://doaccircle.com/
◼ Buy The Diary Of A CEO book here - https://smarturl.it/DOACbook
◼ The 1% Diary is back - limited time only: https://bit.ly/3YFbJbt
◼ The Diary Of A CEO Conversation Cards: https://linkly.link/2hm7r
◼ Get email updates - https://bit.ly/diary-of-a-ceo-yt
◼ Follow Steven - https://g2ul0.app.link/gnGqL4IsKKb
Sponsors:
Wispr - Get 14 days of Wispr Flow for free at https://wisprflow.ai/steven Eight Sleep - http://eightsleep.com/steven use code STEVEN for up to $350 off. 30-day at-home trial. Free returns. Ekster Link: https://link.thediaryofaceo.com/GSNEWnm
Related listening guides